PERIPROSTHETIC METALLOSIS

This adverse event was reported 16 times

These drugs are most commonly taken by patients reporting PERIPROSTHETIC METALLOSIS:

# Drug Count
0 DENOSUMAB 6
1 ANASTROZOLE 4
2 ANASTROZOLE TABLETS 4
3 LETROZOLE 4
4 LETROZOLE TABLETS 4
5 LEUPROLIDE ACETATE 4
6 RIBOCICLIB 4
7 METHOTREXATE SODIUM 3
8 RISANKIZUMAB-RZAA 3
9 RITUXIMAB-ABBS 3
See all common drugs associated with PERIPROSTHETIC METALLOSIS

PERIPROSTHETIC METALLOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RITUXIMAB-ABBS 3 0.0006
1 RISDIPLAM 1 0.0002
2 CABERGOLINE 1 0.0002
3 ANASTROZOLE TABLETS 4 0.0002
4 FLUOCINONIDE TOPICAL SOLUTION USP, 0.05% 1 0.0002
5 RIBOCICLIB 4 0.0001
6 TESTOSTERONE CYPIONATE 1 0.0001
7 ANASTROZOLE 4 0.0001
8 LETROZOLE TABLETS 4 0.0001
9 LETROZOLE 4 0.0001
See all drugs enriched for association with PERIPROSTHETIC METALLOSIS